Skip to main content

Peer Review reports

From: Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study

Original Submission
22 Jan 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Jun 2024 Reviewed Reviewer Report
1 Jul 2024 Reviewed Reviewer Report
18 Jul 2024 Author responded Author comments - Yunpeng Liu
Resubmission - Version 3
18 Jul 2024 Submitted Manuscript version 3
4 Aug 2024 Reviewed Reviewer Report
9 Aug 2024 Author responded Author comments - Yunpeng Liu
Resubmission - Version 4
9 Aug 2024 Submitted Manuscript version 4
15 Aug 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
20 Aug 2024 Editorially accepted
2 Sep 2024 Article published 10.1186/s12885-024-12831-4

You can find further information about peer review here.

Back to article page